Emily Days

Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4

Colleen M. Niswender, Kari A. Johnson, C. David Weaver et al. · Molecular Pharmacology · 2008 · 186 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity

Alice L. Rodriguez, Mark D. Grier, Carrie K. Jones et al. · Molecular Pharmacology · 2010 · 179 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice

Kristian Kaufmann, Ian M. Romaine, Emily Days et al. · ACS Chemical Neuroscience · 2013 · 154 citations

Life Sciences, Neuroscience, Pharmacology +17

Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity

Joy E. Marlo, Colleen M. Niswender, Emily Days et al. · Molecular Pharmacology · 2008 · 149 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2

Eric Delpire, Emily Days, L. Michelle Lewis et al. · Proceedings of the National Academy of Sciences · 2009 · 143 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15